Sue Preston

Ms. Sue Preston brings over 20 years of experience in implementing innovative regulatory and quality strategies for timely product approval and life-cycle management for various globally marketed products. She began her career with the NIH and was subsequently responsible for reviewing and approving biologics and complex polymers at the FDA/CBER. An experienced pharmaceutical executive, Sue devised successful development strategies for novel technologies for biopharmaceuticals, cell therapies, small molecules, drug delivery systems, and diagnostics, and was responsible for directing the development of over 60 product approvals marketed in over 40 countries. She has held positions of increasing responsibility at Baxter Healthcare, Medarex, Alpha Therapeutic Corporation, and Chiron Corporation.